Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucas Sideris

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|April 19, 2019
Correlation between incremental remifentanil doses and the Nociception Level (NOL) index response after intraoperative noxious stimuliEtienne Renaud-Roy, Pierre-André Stöckle, Sarah Maximos, et al.
Annals of Surgical Oncology|August 12, 2024
Predictive Value of C-Reactive Protein for Infectious Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Single-Center Prospective StudyJanyssa Charbonneau, Alexandre Brind'Amour, Lucas Sideris, et al.
Surgery|September 11, 2018
The location of the primary colon cancer has no impact on outcomes in patients undergoing cytoreductive surgery for peritoneal metastasisJulien Péron, Frederic Mercier, Jean-Jacques Tuech, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 1, 2024
Single preoperative radiation therapy with delayed surgery for low-risk breast cancer: Oncologic outcome, toxicity and cosmesis of the SPORT-DS phase I trialDanny Lavigne, Tarek Hijal, Peter Vavassis, et al.
Current Oncology (Toronto, Ont.)|December 22, 2022
The Impact of Computed Tomography Measurements of Sarcopenia on Postoperative and Oncologic Outcomes in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal ChemotherapyMaher Al Khaldi, Massine Fellouah, Pierre Drolet, et al.
International Journal of Molecular Sciences|January 11, 2024
A Phase II Exploratory Study to Identify Biomarkers Predictive of Clinical Response to Regorafenib in Patients with Metastatic Colorectal Cancer Who Have Failed First-Line TherapyKaren Gambaro, Maud Marques, Suzan McNamara, et al.
Clinical Colorectal Cancer|April 28, 2016
A Randomized, Phase II Trial of Cetuximab With or Without PX-866, an Irreversible Oral Phosphatidylinositol 3-Kinase Inhibitor, in Patients With Metastatic Colorectal CarcinomaDaniel W Bowles, Mark Kochenderfer, Allen Cohn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2014
Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC studyJean-Francois Boileau, Brigitte Poirier, Mark Basik, et al.
Clinical Colorectal Cancer|November 25, 2023
Real-World Safety and Effectiveness of a Bevacizumab Biosimilar (ABP 215) in Metastatic Colorectal Cancer Patients in CanadaWinson Y Cheung, Setareh Samimi, Kim Ma, et al.
Clinical and Translational Medicine|May 1, 2021
Copy number and transcriptome alterations associated with metastatic lesion response to treatment in colorectal cancerKaren Gambaro, Maud Marques, Suzan McNamara, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|April 19, 2019
Correlation between incremental remifentanil doses and the Nociception Level (NOL) index response after intraoperative noxious stimuliEtienne Renaud-Roy, Pierre-André Stöckle, Sarah Maximos, et al.
Annals of Surgical Oncology|August 12, 2024
Predictive Value of C-Reactive Protein for Infectious Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Single-Center Prospective StudyJanyssa Charbonneau, Alexandre Brind'Amour, Lucas Sideris, et al.
Surgery|September 11, 2018
The location of the primary colon cancer has no impact on outcomes in patients undergoing cytoreductive surgery for peritoneal metastasisJulien Péron, Frederic Mercier, Jean-Jacques Tuech, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 1, 2024
Single preoperative radiation therapy with delayed surgery for low-risk breast cancer: Oncologic outcome, toxicity and cosmesis of the SPORT-DS phase I trialDanny Lavigne, Tarek Hijal, Peter Vavassis, et al.
Current Oncology (Toronto, Ont.)|December 22, 2022
The Impact of Computed Tomography Measurements of Sarcopenia on Postoperative and Oncologic Outcomes in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal ChemotherapyMaher Al Khaldi, Massine Fellouah, Pierre Drolet, et al.
International Journal of Molecular Sciences|January 11, 2024
A Phase II Exploratory Study to Identify Biomarkers Predictive of Clinical Response to Regorafenib in Patients with Metastatic Colorectal Cancer Who Have Failed First-Line TherapyKaren Gambaro, Maud Marques, Suzan McNamara, et al.
Clinical Colorectal Cancer|April 28, 2016
A Randomized, Phase II Trial of Cetuximab With or Without PX-866, an Irreversible Oral Phosphatidylinositol 3-Kinase Inhibitor, in Patients With Metastatic Colorectal CarcinomaDaniel W Bowles, Mark Kochenderfer, Allen Cohn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2014
Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC studyJean-Francois Boileau, Brigitte Poirier, Mark Basik, et al.
Clinical Colorectal Cancer|November 25, 2023
Real-World Safety and Effectiveness of a Bevacizumab Biosimilar (ABP 215) in Metastatic Colorectal Cancer Patients in CanadaWinson Y Cheung, Setareh Samimi, Kim Ma, et al.
Clinical and Translational Medicine|May 1, 2021
Copy number and transcriptome alterations associated with metastatic lesion response to treatment in colorectal cancerKaren Gambaro, Maud Marques, Suzan McNamara, et al.
Pageof 7